drugset / Trial / NCT02225353

Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery

NCT02225353

RandomizedParallel-groupOpen-labelPrevention

Summary

Assess the efficacy of 2 Cervical Pessaries containing 6.3 g and 7.7 g micronized progesterone for the prevention of preterm delivery, established through spontaneous birth before gestation weeks 32 (31 weeks and 6 days) and 34 (33 weeks and 6 days), when the pessary is inserted during weeks 16th and 24th and removed at 36 weeks and 6 days in pregnant women at high risk of premature birth.

Timeline

Start
2013-09-02
Primary completion
2017-03-13
Completion
2017-03-13

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg Other
Subject Progesterone Other / unclassified 6.3 g Other
Subject Progesterone Other / unclassified 7.7 g Other

Indications

No indication recorded.